Substituted pyrazolopyridines as potent and selective PDE5 inhibitors: potential agents for treatment of erectile dysfunction.

作者信息

Yu G, Mason H J, Wu X, Wang J, Chong S, Dorough G, Henwood A, Pongrac R, Seliger L, He B, Normandin D, Adam L, Krupinski J, Macor J E

机构信息

Discovery Chemistry, Drug Metabolism and Pharmacokinetics, Drug Safety, and Metabolic & Cardiovascular Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400, USA.

出版信息

J Med Chem. 2001 Mar 29;44(7):1025-7. doi: 10.1021/jm0155042.

DOI:10.1021/jm0155042

PMID:11297448

Abstract

摘要

相似文献

Substituted pyrazolopyridines as potent and selective PDE5 inhibitors: potential agents for treatment of erectile dysfunction.

J Med Chem. 2001 Mar 29;44(7):1025-7. doi: 10.1021/jm0155042.

N-3-substituted imidazoquinazolinones: potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunction.

J Med Chem. 2000 Apr 6;43(7):1257-63. doi: 10.1021/jm000081+.

Optimization of substituted N-3-benzylimidazoquinazolinone sulfonamides as potent and selective PDE5 inhibitors.

J Med Chem. 2000 Dec 28;43(26):5037-43. doi: 10.1021/jm000336j.

Substituted pyrazolopyridopyridazines as orally bioavailable potent and selective PDE5 inhibitors: potential agents for treatment of erectile dysfunction.

J Med Chem. 2003 Feb 13;46(4):457-60. doi: 10.1021/jm0256068.

Quinolines as extremely potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunction.

Bioorg Med Chem Lett. 2004 Mar 22;14(6):1577-80. doi: 10.1016/j.bmcl.2003.12.090.

Pyrimidinylpyrroloquinolones as highly potent and selective PDE5 inhibitors for treatment of erectile dysfunction.

J Med Chem. 2002 Sep 12;45(19):4094-6. doi: 10.1021/jm025545d.

SAR development of polycyclic guanine derivatives targeted to the discovery of a selective PDE5 inhibitor for treatment of erectile dysfunction.

Bioorg Med Chem Lett. 2004 Mar 8;14(5):1291-4. doi: 10.1016/j.bmcl.2003.12.027.

Design and synthesis of xanthine analogues as potent and selective PDE5 inhibitors.

Bioorg Med Chem Lett. 2002 Nov 4;12(21):3149-52. doi: 10.1016/s0960-894x(02)00646-7.

Highly potent and selective chiral inhibitors of PDE5: an illustration of Pfeiffer's rule.

Bioorg Med Chem Lett. 2008 Dec 1;18(23):6033-6. doi: 10.1016/j.bmcl.2008.10.037. Epub 2008 Oct 11.

1,7- and 2,7-naphthyridine derivatives as potent and highly specific PDE5 inhibitors.

Bioorg Med Chem Lett. 2003 Jul 21;13(14):2341-5. doi: 10.1016/s0960-894x(03)00440-2.

引用本文的文献

An overview on pharmaceutical applications of phosphodiesterase enzyme 5 (PDE5) inhibitors.

Mol Divers. 2024 Nov 27. doi: 10.1007/s11030-024-11016-2.

Synthesis of quinoline derivatives: discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer's disease.

Eur J Med Chem. 2013 Feb;60:285-94. doi: 10.1016/j.ejmech.2012.12.009. Epub 2012 Dec 14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验